DKK1 and plasma cell myeloma: DKK1 vaccines helped to elicit immune responses to alleviate myeloma in the murine MOPC-21 myeloma model, with remarkable therapeutic efficacy in tumor inhibition experiments. Furthermore, a multiepitope DKK1 vaccine could attenuate bone erosion and lower the disease incidence of arthritis in CIA mice